• Calpain Overactivation Disrupts Offspring Cognition via BDNF

  2026-06-11

  A recent study demonstrates that maternal non-obstetric surgery during pregnancy leads to excessive calpain activity in offspring, disrupting hippocampal BDNF/TrkB signaling and impairing cognitive development. Pharmacological inhibition of calpain with MDL 28170 partially restores neuronal integrity and function, offering mechanistic insight and translational potential for neuroprotection research.

• Collagen VI-Enriched ECM Scaffolds Advance iPSC-Islet Organo

  2026-06-10

  This study demonstrates that collagen VI-enriched decellularized amniotic membrane (dAM) scaffolds significantly enhance the viability, maturation, and engraftment of iPSC-derived islet organoids. The findings provide a robust foundation for engineering physiologically relevant islet microenvironments, with direct implications for diabetes cell therapy.

• BRD4770: Optimizing G9a Histone Methyltransferase Inhibition

  2026-06-10

  This article delivers a scenario-driven guide for biomedical researchers seeking robust, reproducible cell-based epigenetic assays using BRD4770 (SKU B4837). Through real-world Q&A, it demonstrates how this G9a histone methyltransferase inhibitor addresses workflow consistency, data interpretation, and vendor reliability, with actionable protocol insights and reference to validated literature.

• Concanavalin A Targets Conserved N-Glycans for Broad Coronav

  2026-06-09

  This study demonstrates that the plant lectin concanavalin A (ConA) inhibits coronavirus entry by binding to phylogenetically conserved N-linked glycans on the spike protein, effectively blocking membrane fusion. These findings reveal stable structural vulnerabilities on the spike, suggesting a promising strategy for next-generation broad-spectrum antiviral development.

• Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301): T

  2026-06-09

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) address the need for efficient, low-background capture and rapid isolation of biotinylated molecules in protein, nucleic acid, and interaction studies. These beads are not suitable for applications requiring the capture of unmodified or non-biotinylated molecules, or workflows incompatible with BSA or sodium azide.

• NSP2-MYB Module Regulates Flavonoid Biosynthesis in Nodule S

  2026-06-08

  Gao et al. (2026) uncover a regulatory module in Medicago truncatula, where NSP2 and MYB40 interact to control flavonoid biosynthesis and enhance symbiotic efficiency under nutrient stress. This finding clarifies how plants integrate metabolic and symbiotic signals to optimize nitrogen acquisition, with implications for plant-microbe interaction research.

• KR-12 Human Antimicrobial Peptide: Applied Research Protocol

  2026-06-08

  KR-12, the smallest bioactive fragment of LL-37, offers potent, selective antimicrobial and anti-biofilm activity with minimal cytotoxicity, making it a versatile research tool. This guide translates recent mechanistic insights into actionable protocols, comparative advantages, and troubleshooting strategies for advanced infection and immunomodulatory studies.

• Mitoxantrone HCl Allosterically Disrupts ERα to Overcome Res

  2026-06-07

  Wang et al. reveal that Mitoxantrone HCl, a DNA topoisomerase II inhibitor, targets the previously unexplored ERα DBD-LBD interface, triggering rapid proteasomal degradation of both wild-type and resistant mutant estrogen receptors. This novel allosteric mechanism offers an alternative for overcoming therapy resistance in luminal breast cancer and establishes the DBD-LBD interface as a druggable site for nuclear receptor modulation.

• Miltefosine Promotes Neutrophil Differentiation via ERK Path

  2026-06-06

  A recent study demonstrates that Miltefosine, a bioactive PI3K/Akt inhibitor, activates the Ras/MEK/ERK pathway to restore neutrophil differentiation and bone marrow recovery in models of leukopenia. These findings offer a mechanistic foundation for using Miltefosine to address immune suppression following irradiation or chemotherapy.

• Redefining Cell Death Pathways: Cathepsin B Inhibition in Tr

  2026-06-05

  This thought-leadership article offers translational researchers a mechanistic and strategic perspective on the role of cathepsin B in necroptosis, cancer metastasis, and immune regulation. Drawing on recent evidence linking MLKL polymerization-induced lysosomal permeabilization to cathepsin B-mediated cell death, it highlights how the selective cathepsin B inhibitor CA-074 (APExBIO) enables high-precision experimental interrogation and opens new avenues for therapeutic innovation.

• Rapamycin (Sirolimus): Applied mTOR Inhibition in Cell Model

  2026-06-05

  Rapamycin (Sirolimus) stands out as a gold-standard mTOR pathway inhibitor for dissecting cell proliferation, apoptosis, and metabolic reprogramming in cancer, immunology, and mitochondrial disease research. This article delivers actionable protocols, troubleshooting insights, and a practical translation of new findings on autophagy modulation in oxidative stress models, enabling researchers to maximize the reproducibility and interpretability of their studies.

• Sulfachloropyridazine and Microbiota Response in E. tenella-

  2026-06-04

  This study systematically investigates how sulfachlorpyridazine, ethanamizuril, and their combination influence cecal microbiota composition and metabolic profiles in chickens challenged with Eimeria tenella. The findings highlight drug-specific effects on microbial and metabolic restoration, offering new insights for targeted interventions in avian coccidiosis models.

• Imatinib Hydrochloride: Precision Tyrosine Kinase Inhibition

  2026-06-04

  Imatinib hydrochloride (STI571 hydrochloride) is a gold-standard tyrosine kinase inhibitor, empowering cancer researchers to dissect and modulate v-Abl, c-Kit, and PDGFR signaling with high reproducibility. This guide translates recent mechanistic discoveries into practical workflows, advanced applications, and troubleshooting strategies to maximize experimental success in chronic myelogenous leukemia and gastrointestinal stromal tumor models.

• Perifosine (KRX-0401): Optimizing Akt Pathway & Apoptosis As

  2026-06-03

  Perifosine (KRX-0401) offers a unique edge in apoptosis and Akt/mTOR pathway research, enabling robust modulation of cancer and neuroprotection signaling. Leverage data-driven workflows and troubleshooting strategies for reproducible, high-impact results in both in vitro and in vivo studies.

• Advancing In Vitro Drug Response Evaluation in Cancer Resear

  2026-06-03

  Schwartz's dissertation introduces a refined approach to distinguishing cell death from growth arrest in cancer drug screening, addressing a critical gap in the interpretation of in vitro results. These insights improve the precision of anticancer compound assessments and support the development of more predictive preclinical models.

450 records 15/30 page Previous Next First page 上5页 1112131415 下5页 Last page